Skin Conditioning
RETINOYL TRIPEPTIDE-35
Safety score · 0–100
Caution
Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.
A peptide conjugate of all-trans retinoic acid (tretinoin), a prescription-only drug not authorized as a cosmetic ingredient in the EU. Real teratogenic and irritation risks make it inappropriate for OTC skincare.
Function
Skin benefits
- Potential anti-aging effects via retinoid signaling
- Skin renewal stimulation
Known concerns
- Conjugate of all-trans retinoic acid — a prescription drug
- Teratogenic potential — unsafe in pregnancy
- Skin irritation, redness, peeling
- EU restricts retinoic acid in cosmetics; tretinoin not allowed as cosmetic active
References
EU CosIng database
European Commission cosmetic ingredient registry: regulatory status, restrictions, authorised functions.
Related skin conditionings
Check your shelf
Find RETINOYL TRIPEPTIDE-35 in your products.
Scan any cosmetic product with LuxSense to see if it contains RETINOYL TRIPEPTIDE-35 and get a full ingredient breakdown with safety scores.
This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve, so always read the physical product label and consult a healthcare professional for personal concerns.